Literature DB >> 10427865

In vitro study of biosynthesis of protoporphyrin IX induced by delta-aminolevulinic acid in normal and cancerous cells of the human cervix.

E R Gallegos1, I DeLeón Rodríguez, L A Martínez Guzmán, A J Pérez Zapata.   

Abstract

BACKGROUND: delta-Aminolevulinic acid (ALA) is recognized as the starter in the biosynthesis of the heme group, the structural basis of cytochromes, chlorophylls, biliary pigments, and other porphyrins. It is the first intermediary in the biosynthesis of protoporphyrin IX (PpIX), and of the heme group. PpIX is present in low concentration in normal cells, and in high concentration in tumor cells.
METHODS: The accumulation of protoporphyrin IX (PpIX) induced by delta-aminolevulinic acid (ALA) was tested in two cervico-uterine cancer cell lines (HeLa and CaLo), and in normal human cervical epithelial (NHCE) cells.
RESULTS: The optimal concentration of ALA that induced maximum levels of intra- and extracellular accumulation of PpIX in both HeLa and NHCE cells was 300 micrograms of ALA/mL, and for CaLo cells, 150 micrograms/mL. The viability of HeLa, CaLo, and NHCE cells exposed to ALA measured 81, 98, and 84%, respectively. The optimal time for accumulation of PpIX, both intra- and extracellular, was 4 h for HeLa and NHCE cells and 5 h for CaLo cells per 24 h of exposure to optimal concentrations of ALA. After the maximum level of PpIX accumulation was reached, there was a gradual decrease until there was only a small quantity. A statistically significant difference (p < 0.0001) was found in the accumulation of PpIX, depending on the concentrations of ALA used as well as between cervical cancer cell lines and NHCE cells (p < 0.0001). The concentration ratio of PpIX for NHCE and HeLa cells was 1:7, and for NHCE and CaLo cells, 1:5.
CONCLUSIONS: These results are important for determining the usefulness of the sensitizer (PpIX).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427865     DOI: 10.1016/s0188-0128(99)00013-5

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

1.  Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes.

Authors:  Stacy R Millon; Julie H Ostrander; Siavash Yazdanfar; J Quincy Brown; Janelle E Bender; Anita Rajeha; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

2.  Laser-induced effects in different biological samples.

Authors:  M Atif; S Firdous; M Nawaz
Journal:  Lasers Med Sci       Date:  2010-02-20       Impact factor: 3.161

3.  Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.

Authors:  José Bueno-Carrazco; Violeta Castro-Leyva; Fanny García-Gomez; Mario Solís-Paredes; Eva Ramon-Gallegos; Alfredo Cruz-Orea; Pilar Eguía-Aguilar; Francisco Arenas-Huertero
Journal:  Childs Nerv Syst       Date:  2012-06-19       Impact factor: 1.475

4.  Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynecological lesions of intraepithelial form.

Authors:  Paul A McCarron; Ryan F Donnelly; Brendan F Gilmore; A David Woolfson; Raymond McClelland; Agnieszka Zawislak; John H Price
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

5.  Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.

Authors:  Sanjay Anand; Golara Honari; Tayyaba Hasan; Paul Elson; Edward V Maytin
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

6.  Comparative study of phototoxicity of protoporphyrin IX synthetic and extracted from ssp Rattus novergicus albinus rats toward murine melanoma cells.

Authors:  E R Reis; L P Ferreira; E M D Nicola; I Borissevitch
Journal:  Eur Biophys J       Date:  2018-02-16       Impact factor: 1.733

7.  Determination of LMF binding site on a HSA-PPIX complex in the presence of human holo transferrin from the viewpoint of drug loading on proteins.

Authors:  Zohreh Sattar; Mohammad Reza Saberi; Jamshidkhan Chamani
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.